132 related articles for article (PubMed ID: 2379325)
21. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients.
McGregor SJ; Brock JH; Briggs JD; Junor BJ
Nephrol Dial Transplant; 1987; 2(2):104-8. PubMed ID: 3112647
[TBL] [Abstract][Full Text] [Related]
22. [Functional activity of monocytes-macrophages and neutrophils of blood and peritoneal effluent in patients with end-stage kidney failure maintained by permanent peritoneal dialysis at an outpatient setting].
Romanova LA; Lugovskaia SA; Shutov EV; Levina AA; Frolova OE; Korovina VI
Klin Lab Diagn; 2001 Mar; (3):44-7. PubMed ID: 12014080
[No Abstract] [Full Text] [Related]
23. Peritoneal macrophages during peritonitis. Phenotypic studies.
Hart PH; Jones CA; Finlay-Jones JJ
Clin Exp Immunol; 1992 Jun; 88(3):484-91. PubMed ID: 1606734
[TBL] [Abstract][Full Text] [Related]
24. Flow cytometric study of immunocompetent cell phenotypes and phagocytosis in CAPD effluent.
Brando B; Galato R; Seveso M; Sommaruga E; Busnach G; Minetti L
ASAIO Trans; 1988; 34(3):441-4. PubMed ID: 3264175
[TBL] [Abstract][Full Text] [Related]
25. Inflammatory fluids regulate TNF-alpha, but not IL-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis.
Hart PH; Jones CA; Finlay-Jones JJ
J Leukoc Biol; 1993 Mar; 53(3):309-19. PubMed ID: 7681094
[TBL] [Abstract][Full Text] [Related]
26. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
[TBL] [Abstract][Full Text] [Related]
27. Characterization of circulating monocytes expressing HLA-DR or CD71 and related soluble factors for 2 weeks after severe, non-thermal injury.
Walsh DS; Thavichaigarn P; Pattanapanyasat K; Siritongtaworn P; Kongcharoen P; Tongtawe P; Yongvanitchit K; Jiarakul N; Dheeradhada C; Pearce FJ; Wiesmann WP; Webster HK
J Surg Res; 2005 Dec; 129(2):221-30. PubMed ID: 16045935
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis.
Fieren MW; Van den Bemd GJ; Bonta IL
Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505
[TBL] [Abstract][Full Text] [Related]
29. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients.
Lin CY; Ku WL; Huang TP
Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD.
Suassuna JH; Das Neves FC; Hartley RB; Ogg CS; Cameron JS
Kidney Int; 1994 Aug; 46(2):443-54. PubMed ID: 7967356
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen peroxide release by OKIa1 (anti DR--monoclonal antibody) resistant alveolar macrophages in tuberculosis.
Selvaraj P; Rajiswamy ; Vijayan VK; Prabhakar R; Narayanan PR
Indian J Chest Dis Allied Sci; 1989; 31(3):141-9. PubMed ID: 2638649
[TBL] [Abstract][Full Text] [Related]
32. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
Fieren MW; van den Bemd GJ; Bonta IL
Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of 25-OH-vitamin D3 by peritoneal macrophages from CAPD patients.
Shany S; Rapoport J; Zuili I; Gavriel A; Lavi N; Chaimovitz C
Kidney Int; 1991 May; 39(5):1005-11. PubMed ID: 2067195
[TBL] [Abstract][Full Text] [Related]
34. Immuno-effector characteristics of peritoneal cells during CAPD treatment: a longitudinal study.
Betjes MG; Tuk CW; Struijk DG; Krediet RT; Arisz L; Hoefsmit EC; Beelen RH
Kidney Int; 1993 Mar; 43(3):641-8. PubMed ID: 8455363
[TBL] [Abstract][Full Text] [Related]
35. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis.
Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086
[TBL] [Abstract][Full Text] [Related]
36. Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum.
Fricke H; Hartmann J; Sitter T; Steldinger R; Rieber P; Schiffl H
Kidney Int; 1996 May; 49(5):1386-95. PubMed ID: 8731104
[TBL] [Abstract][Full Text] [Related]
37. Diversity in peritoneal macrophage response of CAPD patients to 1,25-dihydroxyvitamin D3.
Levy R; Klein J; Rubinek T; Alkan M; Shany S; Chaimovitz C
Kidney Int; 1990 May; 37(5):1310-5. PubMed ID: 2161062
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-1 beta, -6 and interferon-gamma productions in patients undergoing continuous ambulatory peritoneal dialysis.
Choi KH; Lee IH; Shin SK; Noh HJ; Kang SW; Lee HY; Han DS
Yonsei Med J; 1998 Jun; 39(3):240-6. PubMed ID: 9664829
[TBL] [Abstract][Full Text] [Related]
39. Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions.
Bos HJ; Meyer F; de Veld JC; Beelen RH
Kidney Int; 1989 Jul; 36(1):20-6. PubMed ID: 2681926
[TBL] [Abstract][Full Text] [Related]
40. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
